Omnicell Corp (OMCL) Market Cap to Earnings

Omnicell, Inc. (OMCL) focuses on SaaS solutions and robotics to eliminate medical errors. The company's fundamental P/E multiple on GURU.Markets reflects investor confidence trends, where the 36.50 mark captures this metric. High barriers to entry are driven by strict FDA and HIPAA regulations. Dominance in the hospital automation segment guarantees stable margins due to the complexity of infrastructure migration.

Price to Earnings Ratio: Omnicell Inc (OMCL) for 07/04/2022 - 11/13/2026

Comprehensive metric breakdowns and analytics for Omnicell Corp (OMCL)

- current price and projected stock value:

Share Price omnicell.com|OMCL - Price Target Chart

- market capitalization details:

Market Value Omnicell, Inc.|OMCL - Total Company Value

- book value of equity indicators:

Accounting Value per Share Omnicell|OMCL - Company Book Value|Capitalization to Book Value Ratio omnicell.com|OMCL - Company Total Assets

- company liabilities and liquidity data:

- company profitability and valuation multiples indicators:

OMCL - Net Income|Expected Net Income Omnicell, Inc.|OMCL - P/E Multiple|Market Cap to Projected Earnings Omnicell Inc|OMCL - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Omnicell, Inc.|OMCL - Operating profit EBITDA|Net earnings per share for the last 12 months Omnicell|OMCL - Net earnings per share for the last 12 months|Year-over-year net earnings per share change for the last twelve months omnicell.com|OMCL - Earnings per share growth in current year|Expected net earnings per share growth next year Omnicell, Inc.

- sales volume and revenue indicators:

OMCL - Company Revenue|Company Future Sales Volume omnicell.com|OMCL - P/S Multiple|Forward Price-to-Revenue Multiple Omnicell, Inc.

Summary company analysis:OMCL (omnicell.com)

Conservative capital demands transparency in business valuation relative to its ability to generate real income. This indicator measures market capitalization through the lens of net income to determine the premium for future growth, which in the case of Omnicell, Inc. (OMCL) reflects the demand for pharmacy robotics and the transition to a SaaS model. Analyzing the P/E valuation multiple allows for the identification of an entry point when the company's technological potential is undervalued.

Analysis of competing companies